Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease

Authors:

Abstract
No abstract available
Funding Information
  • The Netherlands Organization for Scientific Research (ZonMW Vici 918.86.616, Mozaiek 017.003.084)
  • the Dutch Medicines Evaluation Board (MEB/CBG)
  • the European Community's Seventh Framework Programme (241679)
  • the Dutch Health Care Insurance Board (CVZ)
  • the Royal Dutch Pharmacists Association (KNMP)
  • Top Institute Pharma
  • the EU Innovative Medicines Initiative (IMI)
  • the Dutch Medicines Evaluation Board
  • the Dutch Ministry of Health and Industry
  • GlaxoSmithKline
  • Pfizer